Paul Atkins, Trump’s SEC pick, says crypto regulation will be his top focus, aiming for clear rules to reduce confusion and support market innovation.

INmune Bio Inc. (NASDAQ: INMB) (the "Company"), a clinical-stage inflammation and immunology company focused on developing treatments that harness ...